E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 4/8/2015 in the Prospect News PIPE Daily.

Drug Free Solution raises $200,000 through private placement of stock

Company sells 2 million common shares at $0.10 per share in offering

By Devika Patel

Knoxville, Tenn., April 8 – Drug Free Solution Inc. settled a $200,000 private placement of stock on March 26, according to an 8-K filing with the Securities and Exchange Commission.

The company sold 2 million common shares at $0.10 apiece, which is a 33.33% discount to the March 25 closing share price of $0.15.

Proceeds will fund operations.

The East Hampton, N.Y., company’s pioneering product is its three-step process that combines self-analysis, breath and language.

Issuer:Drug Free Solution Inc.
Issue:Common stock
Amount:$200,000
Shares:2 million
Price:$0.10
Warrants:No
Settlement date:March 26
Stock symbol:OTCBB: DSOL
Stock price:$0.15 at close March 25
Market capitalization:$24.8 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.